These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

71 related items for PubMed ID: 11178445

  • 1. An in vitro alternative to the mouse neutralisation assay for potency testing of betatoxoid containing Clostridium, perfringens type B and type C vaccines for veterinary use.
    Ebert E, Kusch M, Öppling V, Werner E, Cussler K.
    ALTEX; 1996; 13(2):68-75. PubMed ID: 11178445
    [Abstract] [Full Text] [Related]

  • 2. Quality assurance of C. perfringens epsilon toxoid vaccines--ELISA versus mouse neutralisation test.
    Rosskopf-Streicher U, Volkers P, Noeske K, Werner E.
    ALTEX; 2004; 21 Suppl 3():65-9. PubMed ID: 15057410
    [Abstract] [Full Text] [Related]

  • 3. Collaborative study for the establishment of a European Pharmacopoeia Biological Reference Preparation for Clostridia antiserum for serological potency testing of veterinary clostridial vaccines.
    Lucken R, Daas A, Behr-Gross ME.
    Dev Biol (Basel); 2002; 111():171-80. PubMed ID: 12678238
    [Abstract] [Full Text] [Related]

  • 4. Development of a cell culture assay for the quantitative determination of vaccination-induced antibodies in rabbit sera against Clostridium perfringens epsilon toxin and Clostridium novyi alpha toxin.
    Borrmann E, Schulze F, Cussler K, Hänel I, Diller R.
    Vet Microbiol; 2006 Apr 16; 114(1-2):41-50. PubMed ID: 16361070
    [Abstract] [Full Text] [Related]

  • 5. Development and prevalidation of alternative methods for the potency testing of C. perfringens vaccines.
    Ebert E, Öppling V, Werner E, Cubetaler K.
    ALTEX; 1998 Apr 16; 15(5):59-61. PubMed ID: 11178544
    [Abstract] [Full Text] [Related]

  • 6. Control of Clostridium perfringens vaccines using an indirect competitive ELISA for the epsilon toxin component - examination of the assay by a collaborative study.
    Rosskopf-Streicher U, Volkers P, Werner E.
    Pharmeuropa Bio; 2004 Jan 16; 2003(2):91-6. PubMed ID: 14960265
    [Abstract] [Full Text] [Related]

  • 7. Development of monoclonal antibodies suitable for use in antigen quantification potency tests for clostridial veterinary vaccines.
    Hauer PJ, Clough NE.
    Dev Biol Stand; 1999 Jan 16; 101():85-94. PubMed ID: 10566780
    [Abstract] [Full Text] [Related]

  • 8. Replacement of the in vivo neutralisation test for efficacy demonstration of tetanus vaccines ad us. vet.
    Rosskopf U, Noeske K, Werner E.
    ALTEX; 2005 Jan 16; 22(3):169-74. PubMed ID: 16186992
    [Abstract] [Full Text] [Related]

  • 9. Development and prevalidation of two different ELISA systems for the potency testing of Clostridium perfringens beta and epsilon-toxoid containing veterinary vaccines.
    Ebert E, Oppling V, Werner E, Cussler K.
    FEMS Immunol Med Microbiol; 1999 Jul 16; 24(3):299-311. PubMed ID: 10397315
    [Abstract] [Full Text] [Related]

  • 10. Veterinary vaccines: In-VITRO--International Veterinary Industry Test Replacement Organisation.
    Redhead K, Lucken R, van de Moer A, Houghton S, Simpson B, Cameron A, Monkton P, Hennesy K, Ellis C.
    Dev Biol Stand; 1999 Jul 16; 101():261-6. PubMed ID: 10566800
    [Abstract] [Full Text] [Related]

  • 11. Pasteurella multocida toxin type D serological assay as an alternative to the toxin neutralisation lethality test in mice.
    Finco-Kent DL, Galvin JE, Suiter BT, Huether MJ.
    Biologicals; 2001 Mar 16; 29(1):7-10. PubMed ID: 11482887
    [Abstract] [Full Text] [Related]

  • 12. [The use of the toxin binding inhibition test for potency testing of Clostridium novyi type B alpha toxoid vaccines].
    Luick K, Gottschaldt J, Schulze F, Werner E, Erler W, Borrmann E.
    Dtsch Tierarztl Wochenschr; 2002 Apr 16; 109(4):178-82. PubMed ID: 11998370
    [Abstract] [Full Text] [Related]

  • 13. Optimisation and establishing of serological methods for the potency testing of immunglobulins against Clostridium tetani-toxin.
    Ebert E, Abu Karim A, Kayser T, Wenig R, Weibetaer K, Wirz M, Pisani G, Schäffner G, Cubetaler K.
    ALTEX; 1998 Apr 16; 15(5):30-32. PubMed ID: 11178535
    [Abstract] [Full Text] [Related]

  • 14. Use of in vitro Vero cell assay and ELISA in the United States potency test of vaccines containing adsorbed diphtheria and tetanus toxoids.
    Gupta RK, Siber GR.
    Dev Biol Stand; 1996 Apr 16; 86():207-15. PubMed ID: 8785950
    [Abstract] [Full Text] [Related]

  • 15. Potency Testing of Swine Erysipelas Vaccines by Serology Results of a Pre-validation Study.
    Rosskopf-Streicher U, Johannes S, Wilhelm M, Gyra H, Cussler K.
    ALTEX; 1999 Apr 16; 16(3):123-128. PubMed ID: 11107318
    [Abstract] [Full Text] [Related]

  • 16. [Development of in vitro methods for the potency testing of clostridial vaccines].
    Borrmann E, Schulze F, Diller R.
    ALTEX; 2001 Apr 16; 18(1):34-6. PubMed ID: 11248848
    [Abstract] [Full Text] [Related]

  • 17. Replacement of the Toxin Neutralisation Test in Mice by in vitro Serological Assay Systems for Potency Testing of Tetanus Toxoid Vaccines for Veterinary Use: Results of a European Collaborative Study.
    Hendriksen CF.
    ALTEX; 1994 Apr 16; 11(5):30-34. PubMed ID: 11178404
    [Abstract] [Full Text] [Related]

  • 18. Development of pertussis serological potency test. Serological assessment of antibody response induced by whole cell vaccine as an alternative to mouse protection in an intracerebral challenge model.
    van der Ark A, van Straaten-van de Kappelle I, Akkermans A, Hendriksen C, van de Donk H.
    Biologicals; 1994 Sep 16; 22(3):233-42. PubMed ID: 7811457
    [Abstract] [Full Text] [Related]

  • 19. Pertussis serological potency test as an alternatively to the intracerebral mouse protection test.
    van der Ark A, van Straaten-van de Kappelle I, Hendriksen C, van de Donk H.
    Dev Biol Stand; 1996 Sep 16; 86():271-81. PubMed ID: 8785956
    [Abstract] [Full Text] [Related]

  • 20. Modified intra-cerebral challenge assay for acellular pertussis vaccines: comparisons among whole cell and acellular vaccines.
    Gaines-Das R, Horiuchi Y, Zhang SM, Newland P, Kim Y, Corbel M, Xing D.
    Vaccine; 2009 Nov 16; 27(49):6824-32. PubMed ID: 19765397
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.